Over-the-counter drug · NDA
Iosat (Potassium iodide) NDC 51803-001
Potassium iodide 130 mg/1 · Tablet · Oral · Anbex Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51803-001-01 | 5180300010151803000101 | 14 TABLET in 1 PACKAGE (51803-001-01)Marketed from Oct 14, 1982 | |
| 51803-001-10 | 5180300011051803000110 | 10 PACKAGE in 1 BAG (51803-001-10) / 14 TABLET in 1 PACKAGE (51803-001-01)Marketed from Aug 16, 2016 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Iosat
- Generic name (nonproprietary)
- potassium iodide
- Active ingredients
- Potassium iodide — 130 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Anbex Inc.NDC labeler code 51803
- Product type
- Over-the-counter drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 018664
- Marketing start
- Listing expires
- Identifiers
- Product ID 51803-001_40435397-14e1-e00c-e063-6294a90a3262SPL ID 40435397-14e1-e00c-e063-6294a90a3262SPL set ID ea98aef8-93b6-4fac-be35-eb17a1a04a92RxCUI 312539, 1111703UNII 1C4QK22F9J
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451803000101followed by a unit qualifier and the quantityPackage 51803-0001-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Uses Helps prevent radioactive iodine from getting into the thyroid gland during a nuclear radiation emergency. Use along with other emergency measures recommended by public officials.
Excerpt only. Read the full label for complete information.
About NDC 51803-001
- What is NDC 51803-001?
- 51803-001 is the product NDC for Iosat (potassium iodide), Potassium iodide 130 mg/1 tablet, listed with the FDA by Anbex Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Iosat (Potassium Iodide).
- What is the active ingredient?
- Potassium iodide.
- Who is the labeler?
- Anbex Inc., NDC labeler code 51803. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Iosat?
- 1 other product NDC are listed under this name. See all Iosat NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Iosat products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Iosatpotassium iodide | Potassium iodide 65 mg/1 | TabletOral | Anbex Inc. | 51803-002 | 51803-0002-0151803-0002-02 |
Other NDCs under NDA 018664
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Iosatpotassium iodide | Potassium iodide 65 mg/1 | TabletOral | Anbex Inc. | 51803-002 |